The Effects of DPP-4 Inhibitors on Plasma Catecholamines and Their Metabolites in Patients with Type 2 Diabetes

被引：0
|
作者：
Park, Ie Byung
Lee, Daeho
Lee, Kiyoung
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-440-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
440-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
    Vitale, Cristiana
    Rosano, Giuseppe M. C.
    Prasad, Krishna
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [32] Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
    Deacon, Carolyn F.
    PEPTIDES, 2018, 100 : 150 - 157
  • [33] Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Contra
    Mueller, U. A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (11) : 547 - 547
  • [34] Effects of DPP-4 inhibitors on cardiovascular outcomes in patients with type 2 diabetes and end-stage renal disease
    Chan, Shang-Yih
    Ou, Shuo-Ming
    Chen, Yung-Tai
    Shih, Chia-Jen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 218 : 170 - 175
  • [35] Effect of dpp-4 inhibitors therapy on left atrial volume index in patients with type 2 diabetes
    Papazafiropoulou, A.
    Trikkalinou, A.
    Tountas, C.
    Theodosis-Georgilas, A.
    Markakis, V.
    Ioannidis, C.
    Bampali, V.
    Petropoulou, K.
    Foussas, S.
    Melidonis, A.
    DIABETOLOGIA, 2016, 59 : S533 - S533
  • [36] NATIONAL COUNCIL OF EXPERTS: THE PLACE OF DPP-4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Shestakova, Marina V.
    Vagapova, Gulnar R.
    Vikulova, Olga K.
    Galstyan, Gagik R.
    Demidova, Tatiana Y.
    Dudinskaya, Ekaterina N.
    Kiseleva, Tatiana P.
    Mkrtumyan, Ashot M.
    Petunina, Nina A.
    Tkacheva, Olga N.
    Fadeev, Valentin V.
    Khalimov, Yuriy S.
    Shestakova, Ekaterina A.
    DIABETES MELLITUS, 2023, 26 (06): : 619 - 625
  • [37] Evaluation of efficacy and safety of DPP-4 inhibitors for Chinese elderly patients with type 2 diabetes mellitus
    Yu, Dong-Ni
    Qiu, Lei
    Ning, Shang-Yong
    Guo, Li-Xin
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01):
  • [38] Evaluation of efficacy and safety of DPP-4 inhibitors for Chinese elderly patients with type 2 diabetes mellitus
    Dong-Ni Yu
    Lei Qiu
    Shang-Yong Ning
    Li-Xin Guo
    Diabetology & Metabolic Syndrome, 12
  • [39] Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study
    Kim, Young-Gun
    Byun, JungHyun
    Yoon, Dukyong
    Jeon, Ja Young
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Park, Rae Woong
    Kim, Hae Jin
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [40] DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment
    Momir Mikov
    Nebojša Pavlović
    Bojan Stanimirov
    Maja Đanić
    Svetlana Goločorbin-Kon
    Karmen Stankov
    Hani Al-Salami
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 1 - 14
12345